Mumbai, April 6 -- Headline equity benchmarks traded with modest losses in the morning trade, mirroring global uncertainty amid rising geopolitical tensions between the US and Iran. Investor sentiment... Read More
Dehradun, April 6 -- Garhwal Post Bureau DEHRADUN, 4 Apr: In a significant escalation of tension between the district administration and the legal fraternity in Dehradun, the practicing lawyers in De... Read More
IPOH, April 6 -- The Ministry of Education (MoE) has ordered all Teacher Education Institute (IPG) campuses to temporarily suspend water and adventure activities following a drowning incident involvin... Read More
Kuala Lampur, April 6 --   SINGAPORE, April 6 - A man who was recently sentenced to jail for mischief has been charged with allegedly vandalising a police car the day after his release, accordin... Read More
India, April 6 -- This Mid-cap Healthcare Stock, engaged in providing hospital, diagnostic, and healthcare services, delivering quality medical care through its network of hospitals and skilled profes... Read More
భారతదేశం, ఏప్రిల్ 6 -- బాలీవుడ్ ప్రముఖ నిర్మాత ఏక్తా కపూర్ ప్రస్తుతం సోషల్ మీడియాలో హాట్ టాపిక్గా మారారు. అయితే ఈసారి ఆమె నిర్మిస్తున్న సినిమాల వల్ల కాదు, తన అద్భుతమైన మేకోవర్ (శరీర ఆకృతి మార్పు) వల్... Read More
Mumbai, April 6 -- Olam Group is a leading US$ 50-plus billion food and agri-business headquartered in Singapore, employing nearly 40,000 people, and majority owned by Temasek Holdings. The 8-year en... Read More
Gorakhpur, April 6 -- Another example of Chief Minister Yogi Adityanath's sensitivity towards daughters was seen on Monday during the Janata Darshan. A girl who came to meet CM Yogi told him that she ... Read More
Singapore, April 6 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... Read More
Singapore, April 6 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More